Trial intelligence / Profile preview

Deep Jugular Lymphovenous Anastomosis for Alzheimer's Disease

NCT07060391Phase 3Not yet recruiting

Sponsor
Shanghai Jiao Tong University School of Medicine
Start
Jul 2025
Primary completion
Jan 2027
01

Overview

Phase 3, randomised, open-label trial (2 arms), sponsored by Shanghai Jiao Tong University School of Medicine. Primary endpoint: Alzheimer's Disease Assessment Scale-Cognitive Subscale at 48 weeks. Planned start Jul 2025; status: not yet recruiting.

Beyond the preview

Go deeper on NCT07060391.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07060391.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call